Journal profile
Cancer Convergence
ISSN 2366-6196 · BMC · United Kingdom
Cancer Convergence: diamond open access (no APC); no APC; review about 36 weeks (community reports); 0 articles in 2025; the journal's website says submissions are paused or closed.
The journal's website says submissions are paused or closed: Cancer Convergence is now archived and no longer receiving submissions with this publisher. All articles published in the journal during its time with Springer will remain fully searchable through our websites. Source ↗Publisher website ·
Scope
Aims, scope and focus
Cancer Convergence is published by BMC. By OpenAlex counts of its recent articles, its largest topics are Cancer Cells and Metastasis, Mathematical Biology Tumor Growth and Cellular Mechanics and Interactions, together about 45.8% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer Cells and MetastasisMedicine25%
- Mathematical Biology Tumor GrowthMathematics12.5%
- Cellular Mechanics and InteractionsBiochemistry, Genetics and Molecular Biology8.3%
- Gene Regulatory Network AnalysisBiochemistry, Genetics and Molecular Biology8.3%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology8.3%
- Hepatocellular Carcinoma Treatment and PrognosisMedicine4.2%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology4.2%
- Angiogenesis and VEGF in CancerBiochemistry, Genetics and Molecular Biology4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
DOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 6OpenAlex ·
- i10-index
- 4OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 8 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 14 |
| 2025 | 0 | 0 | 28 |
| 2024 | 0 | 0 | 19 |
| 2023 | 0 | 0 | 25 |
| 2022 | 0 | 0 | 34 |
| 2021 | 0 | 0 | 35 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 36 weeksLetPub ·
- Submission to publication (journal-reported)
- about 36 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY, CC0 | |
| OpenAlex | USD 1,340 / EUR 1,140 / GBP 1,040 | — | — | |
| LetPub | EUR 1,140 / USD 1,340 / GBP 1,040 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- BMC
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2366-6196
- Official links
- Journal homepage ↗OpenAlex
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Cancer Convergence
How long does peer review take at Cancer Convergence?
Authors report an average review time of about 36 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Cancer Convergence?
According to LetPub and DOAJ records, Cancer Convergence is indexed in DOAJ.
Is Cancer Convergence open access, and what is the APC?
Cancer Convergence is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .